Amelia S. Petry

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Larissa Wenning, William D. Hanley, Diana M. Brainard et al. · Antimicrobial Agents and Chemotherapy · 2009 · 160 citations · Full text

Immunology, Pharmacotherapy, Antimicrobial Chemotherapy +20

Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects

Marian Iwamoto, Larissa Wenning, Goutam C. Mistry et al. · Clinical Infectious Diseases · 2008 · 87 citations

Translational Medicine, Allergy, Healthy Subjects +12

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

Marian Iwamoto, Kelem Kassahun, Matthew D. Troyer et al. · The Journal of Clinical Pharmacology · 2007 · 80 citations

Vitro/in Vivo Correlation, Pharmacotherapy, Antiviral Drug +16

Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

Marian Iwamoto, Larissa Wenning, Amelia S. Petry et al. · Antimicrobial Agents and Chemotherapy · 2008 · 65 citations · Full text

Plasma Concentrations, Healthy Subjects, Pharmacological Study +14

Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics

Marian Iwamoto, William D. Hanley, Amelia S. Petry et al. · Antimicrobial Agents and Chemotherapy · 2009 · 44 citations · Full text

Pharmacotherapy, Antiviral Drug, Antiviral Drug Development +19